Pharm Exec

FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis

The FDA approved a once-monthly, single-injection regimen for Omvoh, enhancing convenience for UC patients. Omvoh, an IL-23p19 antagonist, offers bioequivalent efficacy to the previous two-injection ...
Yahoo Finance

Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ...
Healio

Single TLC599 injection superior to placebo for knee osteoarthritis pain over 24 weeks

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — A single injection of TLC599, a liposomal formulation of dexamethasone sodium phosphate, bested ...
Morningstar

Fresenius Kabi Introduces Dalbavancin for Injection (for single-dose regimen use only)

A new addition to Fresenius Kabi’s anti-infective portfolio, Dalbavancin for Injection is indicated for acute bacterial skin and skin structure infections and approved for single-dose regimen use only ...
Monthly Prescribing Reference

FDA Approves Omvoh Single-Injection Maintenance Regimen for Ulcerative Colitis

According to Lilly, the single-injection, citrate-free, maintenance dose will be available in the US as a prefilled pen or prefilled syringe in early 2026. The Food and Drug Administration (FDA) has ...